October 23, 2011

Houston Post - July 3, 1975, Page 3A

Cancer Pioneer's services planned

A memorial service for Dr. Jeffrey A. Gottlieb, chief of chemotherapy at the University of Texas System Cancer Center's M.D. Anderson Hospital and Tumor Institute will be at 4 p.m. Sunday at Memorial Drive Presbyterian Church.

Gottlieb, 35, died Tuesday after a long struggle with one for of the malignant diseases he worked so hard to conquer.

Since joining the Anderson staff in 1970, Gottlieb had pioneered the use of two new anti-cancer drugs, adriamycin and bleomycin, and had devised better treatments employing the best effects of multiple chemotherapeutic agents for human patients.

Anderson President Dr. R. Lee Clark praised Gottlieb as "a young giant in the field of cancer therapy" and said his innovative drug regimens are being used throughout the world.

Gottlieb was particularly successful in designing combination chemotherapy programs for victims of soft tissue sarcomas and cancers of the thyroid, breast, head and neck and malignant melanoma.

A major accomplishment was his defining the precise dosage of adriamycin to limit its toxic side effects on the heart. He also was a widely respected authority on studying drug action mechanisms of tumor cells grown in cell cultures.

Gottlieb, born in New York City, graduated with honors from Amherst College, then earned his medical degree in 1966 from Harvard Medical School.

After interning in St. Louis and completing a pediatric residency at Children's Hospital in Boston, he spent two years at the Baltimore Cancer Research Center of the National Cancer Institute before moving to Houston.

Gottlieb was an associate professor of medicine in the Anderson Department of Development Therapeutics and executive secretary of the Southwest Oncology Group. He had authored or helped write more than 75 major medical articles on various facets of his basic and clinical research.

"Jeffrey Gottlieb was a most brilliant physician, scientist and administrator. His death is a grave blow to cancer patients around the world," said Dr. Emil J. Freireich, head of the Anderson Department of Developmental Therapeutics.

Gottlieb, who lived at 5231 Lymbar, is survived by his wife, Margery, and two children, Elizabeth Anne and Keith Andrew. The body will be cremated.

No comments: